5-38493734-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001127671.2(LIFR):c.1937C>A(p.Thr646Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00165 in 1,614,082 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001127671.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIFR | NM_001127671.2 | c.1937C>A | p.Thr646Asn | missense_variant | 14/20 | ENST00000453190.7 | NP_001121143.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIFR | ENST00000453190.7 | c.1937C>A | p.Thr646Asn | missense_variant | 14/20 | 2 | NM_001127671.2 | ENSP00000398368 | P1 | |
LIFR | ENST00000263409.8 | c.1937C>A | p.Thr646Asn | missense_variant | 14/20 | 1 | ENSP00000263409 | P1 | ||
LIFR | ENST00000503088.1 | n.2100C>A | non_coding_transcript_exon_variant | 14/15 | 1 | |||||
LIFR | ENST00000506003.5 | c.*115C>A | 3_prime_UTR_variant, NMD_transcript_variant | 4/7 | 3 | ENSP00000426919 |
Frequencies
GnomAD3 genomes AF: 0.00802 AC: 1220AN: 152132Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00206 AC: 518AN: 251466Hom.: 3 AF XY: 0.00153 AC XY: 208AN XY: 135904
GnomAD4 exome AF: 0.000984 AC: 1439AN: 1461832Hom.: 15 Cov.: 31 AF XY: 0.000798 AC XY: 580AN XY: 727224
GnomAD4 genome AF: 0.00808 AC: 1230AN: 152250Hom.: 5 Cov.: 32 AF XY: 0.00818 AC XY: 609AN XY: 74436
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 29, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 13, 2023 | Variant summary: LIFR c.1937C>A (p.Thr646Asn) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0021 in 251466 control chromosomes, predominantly at a frequency of 0.026 within the African or African-American subpopulation in the gnomAD database, including 3 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 23 fold of the estimated maximal expected allele frequency for a pathogenic variant in LIFR causing Stuve-Wiedemann Syndrome phenotype (0.0011), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.1937C>A in individuals affected with Stuve-Wiedemann Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Nine clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (likely pathogenic n=1, benign/likely benign n=8). Based on the evidence outlined above, the variant was classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 13, 2023 | The p.Thr646Asn variant in LIFR is classified as benign because it has been identified in 2.7% (1118/41434) of African chromosomes, including 5 homozygotes by gnomAD (http://gnomad.broadinstitute.org, v.3.1.2). ACMG/AMP Criteria applied: BA1. - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 28, 2019 | This variant is associated with the following publications: (PMID: 28334964) - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 12, 2015 | - - |
Stuve-Wiedemann syndrome Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 15, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Congenital anomaly of kidney and urinary tract Uncertain:1
Uncertain significance, no assertion criteria provided | research | Weber Lab, Hannover Medical School | Feb 15, 2024 | - - |
LIFR-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 04, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Stüve-Wiedemann syndrome 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
Connective tissue disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Feb 10, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at